Evaluating the Effectiveness of Aromatherapy for Alleviating Distress in Breast Cancer Patients Before Radiotherapy.
Recruiting · NCT06766058 · Interventional (participants receive a specific treatment) · Lead sponsor: National Cancer Centre, Singapore
View the official record on ClinicalTrials.gov →Interventions studied
Asian plant extract blendCarrier oil
What this trial is about
ASTER is a multi-part study that aims to prospectively establish evidence for the implementation of aromatherapy as complementary therapy within cancer care in the Singapore context. ASTER 2 study evaluates how extracts from Asian aromatic plants with familiar aromas introduced as inhalation therapy can alleviate distress in breast cancer patients scheduled to undergo radiotherapy (RT).
Who can take part
Age range
21 Years to 99 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Aged 21 years old and above
- Confirmed diagnosis of breast cancer of any stage
- Scheduled to undergo radiotherapy for the first time
- Capable of providing informed consent
Exclusion criteria
- Physically or mentally incapable of providing verbal/written consent
- Known or suspected hypersensitivity/allergy to essential oils or any components of the formulations
- Airway hypersensitivity to fragrances, paint fumes or turpentine
- Taking medications for anxiety (e.g. benzodiazepines) before radiotherapy
- Pregnant, breastfeeding, or intending to conceive during study period
Where it is running
1 location listed.
- National Cancer Centre Singapore - Singapore, Singapore